Europe PMCopen access
Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review
Overall Survival, Progression-free Survival, Recurrent Glioblastoma, Egfr Amplification, Egfr-targeted Therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 304159
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.